Prevalence of methicillin-resistant staphylococcus aureus among healthy residents of Ekosodin community in Benin-City, Nigeria
AbstractPurpose: To determine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in apparently healthy residents of Ekosodin community, a peri-urban settlement, in Benin City, Nigeria.
Method: Nasal swabs collected from 200 randomly selected individuals, aged between 16 and 38 years, were used in the study. Isolates from the swabs were aseptically collected and characterized using standard and established microbiological methods, which included growth and fermentation on mannitol salt agar (MSA), colonial morphology, Gram-staining reaction and biochemical tests. Antimicrobial susceptibility test was performed on Mueller-Hinton agar (MHA) by modified Kirby-Bauer disc diffusion method.
Results: S. aureus was isolated in 49.5 % (n = 99) of the 200 nasal swabs. Among these isolates, 43 % were from male residents and 22.2 % (n = 22) were MRSA. The MRSA isolates indicated relatively high rate of resistance to penicillins, moderate resistance to erythromycin and cefuroxime, and leastresistance to gentamicin, streptomycin, ceftriaxone, ciprofloxacin and co-trimoxazole. There was no significant gender difference in terms of the colonization of S. aureus (p < 0.05).
Conclusion: Many apparently healthy residents of Ekosodin community are nasal carriers of MSRA. The need for rational chemotherapy, routine detection and regular surveillance of MRSA to limit its spread and reduce treatment failures is vital.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.